Robeco Institutional Asset Management B.V. Purchases 168,153 Shares of Stryker Corporation (NYSE:SYK)

Robeco Institutional Asset Management B.V. increased its stake in Stryker Corporation (NYSE:SYK - Free Report) by 109.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 321,247 shares of the medical technology company's stock after purchasing an additional 168,153 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.08% of Stryker worth $119,584,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Mascoma Wealth Management LLC lifted its position in Stryker by 22.7% in the 4th quarter. Mascoma Wealth Management LLC now owns 146 shares of the medical technology company's stock worth $53,000 after buying an additional 27 shares in the last quarter. Lindbrook Capital LLC raised its holdings in shares of Stryker by 2.0% during the fourth quarter. Lindbrook Capital LLC now owns 1,407 shares of the medical technology company's stock worth $507,000 after acquiring an additional 28 shares in the last quarter. Continuum Advisory LLC boosted its position in Stryker by 5.8% during the first quarter. Continuum Advisory LLC now owns 532 shares of the medical technology company's stock valued at $198,000 after purchasing an additional 29 shares during the last quarter. United Community Bank grew its stake in Stryker by 3.4% in the fourth quarter. United Community Bank now owns 904 shares of the medical technology company's stock valued at $325,000 after purchasing an additional 30 shares in the last quarter. Finally, Ironwood Investment Counsel LLC increased its position in Stryker by 0.9% in the 4th quarter. Ironwood Investment Counsel LLC now owns 3,323 shares of the medical technology company's stock worth $1,196,000 after purchasing an additional 30 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 5.90% of the company's stock.

Stryker Trading Up 1.4%

SYK stock traded up $5.65 during trading on Friday, hitting $396.05. The company had a trading volume of 257,911 shares, compared to its average volume of 1,336,753. The firm has a 50-day moving average price of $378.06 and a 200-day moving average price of $375.38. Stryker Corporation has a 12 month low of $314.93 and a 12 month high of $406.19. The company has a quick ratio of 1.00, a current ratio of 1.64 and a debt-to-equity ratio of 0.69. The stock has a market cap of $151.17 billion, a price-to-earnings ratio of 53.49, a PEG ratio of 2.96 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.73 by $0.11. The business had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The firm's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.50 earnings per share. As a group, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a yield of 0.85%. Stryker's dividend payout ratio is currently 45.41%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on SYK shares. Truist Financial boosted their price target on Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a research note on Monday, May 5th. Roth Mkm increased their price target on shares of Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a report on Monday, May 5th. Needham & Company LLC reiterated a "buy" rating and issued a $442.00 price objective on shares of Stryker in a report on Friday, March 21st. Finally, Citigroup reaffirmed a "buy" rating and issued a $455.00 price target (up previously from $443.00) on shares of Stryker in a research report on Thursday, May 22nd. Four equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Stryker presently has an average rating of "Moderate Buy" and an average price target of $427.30.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.